In head and neck as well as lung cancer cells, EGFR mediates HIV+ exosome entry into target cells and participates in exosome-induced cellular signaling, including ERK1/2 phosphorylation, without activating the receptor (26). The gene discussed is MAPK3; the disease is lung carcinoma.